{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:39:31Z","timestamp":1787002771103,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Long noncoding RNAs (lncRNAs) are regarded as crucial regulators in tumor progression. Potassium two pore domain channel subfamily K member 15 and WISP2 antisense RNA 1 (KCNK15-AS1) has been confirmed to inhibit the migration and invasion of pancreatic cancer (PC) cells. However, its downstream mechanism and effect on other cellular functions in PC remain unknown. This study probed the function and potential mechanism of KCNK15-AS1 in PC cell growth. RT-qPCR and western blot were employed to measure gene expression in PC cells. ISH was applied to analyze KCNK15-AS1 expression in PC tissues. Functional assays were utilized to evaluate PC cell proliferation, apoptosis, migration and EMT. Mechanical experiments were adopted to detect gene interaction in PC cells. The obtained data indicated that KCNK15-AS1 was down-regulated in PC cells and tissues. Overexpressing KCNK15-AS1 hindered cell proliferation, migration and EMT while facilitated cell apoptosis in PC. Mechanically, alkylation repair homolog protein 5 (ALKBH5) was verified to induce m\n                    <jats:sup>6<\/jats:sup>\n                    A demethylation of KCNK15-AS1 to mediate KCNK15-AS1 up-regulation. KCNK15-AS1 combined with KCNK15 5\u2019UTR to inhibit KCNK15 translation. Moreover, KCNK15-AS1 recruited MDM2 proto-oncogene (MDM2) to promote RE1 silencing transcription factor (REST) ubiquitination, thus transcriptionally upregulating phosphatase and tensin homolog (PTEN) to inactivate AKT pathway. In conclusion, our study first confirmed that KCNK15-AS1 hinders PC cell growth by regulating KCNK15 and PTEN, suggesting KCNK15-AS1 as a potential biomarker of PC.\n                  <\/jats:p>","DOI":"10.1038\/s41419-021-04401-4","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T16:29:12Z","timestamp":1638376152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["ALKBH5-mediated m6A demethylation of KCNK15-AS1 inhibits pancreatic cancer progression via regulating KCNK15 and PTEN\/AKT signaling"],"prefix":"10.1038","volume":"12","author":[{"given":"Yuan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HongQin","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhilong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1479-2868","authenticated-orcid":false,"given":"Huihui","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9300-4689","authenticated-orcid":false,"given":"Chuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"key":"4401_CR1","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.7314\/APJCP.2015.16.14.5619","volume":"16","author":"V Goral","year":"2015","unstructured":"Goral V. Pancreatic cancer: pathogenesis and diagnosis. Asian Pac J Cancer Prev. 2015;16:5619\u201324.","journal-title":"Asian Pac J Cancer Prev"},{"key":"4401_CR2","first-page":"7","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: Cancer J Clin. 2016;66:7\u201330.","journal-title":"CA: Cancer J Clin"},{"key":"4401_CR3","doi-asserted-by":"publisher","first-page":"826","DOI":"10.31128\/AJGP-06-19-4957","volume":"48","author":"BPT Loveday","year":"2019","unstructured":"Loveday BPT, Lipton L, Thomson BN. Pancreatic cancer: an update on diagnosis and management. Aust J Gen Pract. 2019;48:826\u201331.","journal-title":"Aust J Gen Pract"},{"key":"4401_CR4","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1016\/j.lpm.2019.02.025","volume":"48","author":"C Springfeld","year":"2019","unstructured":"Springfeld C, J\u00e4ger D, B\u00fcchler MW, Strobel O, Hackert T, Palmer DH, et al. Chemotherapy for pancreatic cancer. Presse Med. 2019;48:e159\u2013e74.","journal-title":"Presse Med"},{"key":"4401_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","volume":"378","author":"A Vincent","year":"2011","unstructured":"Vincent A, Herman J, Schulick R, Hruban RH, Goggins M. Pancreatic cancer. Lancet. 2011;378:607\u201320.","journal-title":"Lancet"},{"key":"4401_CR6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","volume":"179","author":"FJ Slack","year":"2019","unstructured":"Slack FJ, Chinnaiyan AM. The role of non-coding RNAs in oncology. Cell 2019;179:1033\u201355.","journal-title":"Cell"},{"key":"4401_CR7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrg2521","volume":"10","author":"TR Mercer","year":"2009","unstructured":"Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155\u20139.","journal-title":"Nat Rev Genet"},{"key":"4401_CR8","doi-asserted-by":"publisher","first-page":"194419","DOI":"10.1016\/j.bbagrm.2019.194419","volume":"1863","author":"EK Robinson","year":"2020","unstructured":"Robinson EK, Covarrubias S, Carpenter S. The how and why of lncRNA function: an innate immune perspective. Biochim Biophys Acta Gene Regul Mech. 2020;1863:194419.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"4401_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3727\/096504016X14549667334007","volume":"23","author":"J Li","year":"2016","unstructured":"Li J, Meng H, Bai Y, Wang K. Regulation of lncRNA and its role in cancer metastasis. Oncol Res. 2016;23:205\u201317.","journal-title":"Oncol Res"},{"key":"4401_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ijbiomac.2018.05.044","volume":"116","author":"H Gao","year":"2018","unstructured":"Gao H, Gong N, Ma Z, Miao X, Chen J, Cao Y, et al. LncRNA ZEB2-AS1 promotes pancreatic cancer cell growth and invasion through regulating the miR-204\/HMGB1 axis. Int J Biol Macromol. 2018;116:545\u201351.","journal-title":"Int J Biol Macromol"},{"key":"4401_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.omtn.2018.09.026","volume":"13","author":"B Liu","year":"2018","unstructured":"Liu B, Wu S, Ma J, Yan S, Xiao Z, Wan L, et al. lncRNA GAS5 reverses EMT and tumor stem cell-mediated gemcitabine resistance and metastasis by targeting miR-221\/SOCS3 in pancreatic cancer. Mol Ther Nucleic Acids. 2018;13:472\u201382.","journal-title":"Mol Ther Nucleic Acids"},{"key":"4401_CR12","doi-asserted-by":"publisher","first-page":"8589","DOI":"10.2147\/CMAR.S186002","volume":"11","author":"H Zhang","year":"2019","unstructured":"Zhang H, Zhang Z, Wang D. Epigenetic regulation of IncRNA KCNKI5-ASI in gastric cancer. Cancer Manag Res. 2019;11:8589\u2013602.","journal-title":"Cancer Manag Res"},{"key":"4401_CR13","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1159\/000491915","volume":"48","author":"Y He","year":"2018","unstructured":"He Y, Hu H, Wang Y, Yuan H, Lu Z, Wu P, et al. ALKBH5 inhibits pancreatic cancer motility by decreasing long non-coding RNA KCNK15-AS1 methylation. Cell Physiol Biochem. 2018;48:838\u201346.","journal-title":"Cell Physiol Biochem"},{"key":"4401_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jgg.2013.10.002","volume":"41","author":"J Liu","year":"2014","unstructured":"Liu J, Jia G. Methylation modifications in eukaryotic messenger RNA. J Genet Genom = Yi Chuan Xue Bao. 2014;41:21\u201333.","journal-title":"J Genet Genom = Yi Chuan Xue Bao"},{"key":"4401_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505:117\u201320.","journal-title":"Nature."},{"key":"4401_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01158-w","volume":"19","author":"X Guo","year":"2020","unstructured":"Guo X, Li K, Jiang W, Hu Y, Xiao W, Huang Y, et al. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner. Mol Cancer. 2020;19:91.","journal-title":"Mol Cancer"},{"key":"4401_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1128-6","volume":"19","author":"B Tang","year":"2020","unstructured":"Tang B, Yang Y, Kang M, Wang Y, Wang Y, Bi Y, et al. m(6)A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling. Mol Cancer. 2020;19:3.","journal-title":"Mol Cancer"},{"key":"4401_CR18","doi-asserted-by":"publisher","unstructured":"Pompura SL, Dominguez-Villar M The PI3K\/AKT signaling pathway in regulatory T-cell development, stability, and function. J Leukocyte Biol. 2018. https:\/\/doi.org\/10.1002\/JLB.2MIR0817-349R.","DOI":"10.1002\/JLB.2MIR0817-349R"},{"key":"4401_CR19","doi-asserted-by":"crossref","unstructured":"Shorning BY, Dass MS, Smalley MJ, Pearson HB. The PI3K-AKT-mTOR pathway and prostate cancer: at the crossroads of AR, MAPK, and WNT signaling. Int J Mol Sci. 2020;21:4507.","DOI":"10.3390\/ijms21124507"},{"key":"4401_CR20","doi-asserted-by":"crossref","first-page":"e12630","DOI":"10.1111\/cpr.12630","volume":"53","author":"QF Ni","year":"2020","unstructured":"Ni QF, Zhang Y, Yu JW, Hua RH, Wang QH, Zhu JW. miR-92b promotes gastric cancer growth by activating the DAB2IP-mediated PI3K\/AKT signalling pathway. Cell Prolif. 2020;53:e12630.","journal-title":"Cell Prolif"},{"key":"4401_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/978-3-030-32656-2_14","volume":"1210","author":"Y Yan","year":"2019","unstructured":"Yan Y, Huang H. Interplay among PI3K\/AKT, PTEN\/FOXO and AR signaling in prostate cancer. Adv Exp Med Biol. 2019;1210:319\u201331.","journal-title":"Adv Exp Med Biol"},{"key":"4401_CR22","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1146\/annurev-biochem-082411-113907","volume":"83","author":"CA Worby","year":"2014","unstructured":"Worby CA, Dixon JE. PTEN. Annu Rev Biochem. 2014;83:641\u201369.","journal-title":"Annu Rev Biochem"},{"key":"4401_CR23","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1002\/jcb.26395","volume":"120","author":"Y Yu","year":"2019","unstructured":"Yu Y, Liang S, Zhou Y, Li S, Li Y, Liao W. HNF1A\/CASC2 regulates pancreatic cancer cell proliferation through PTEN\/Akt signaling. J Cell Biochem. 2019;120:2816\u201327.","journal-title":"J Cell Biochem"},{"key":"4401_CR24","doi-asserted-by":"publisher","first-page":"8010","DOI":"10.18632\/oncotarget.14037","volume":"8","author":"S Ni","year":"2017","unstructured":"Ni S, Wang H, Zhu X, Wan C, Xu J, Lu C, et al. CBX7 suppresses cell proliferation, migration, and invasion through the inhibition of PTEN\/Akt signaling in pancreatic cancer. Oncotarget. 2017;8:8010\u201321.","journal-title":"Oncotarget."},{"key":"4401_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature23451","volume":"548","author":"J Joung","year":"2017","unstructured":"Joung J, Engreitz JM, Konermann S, Abudayyeh OO, Verdine VK, Aguet F, et al. Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood. Nature. 2017;548:343\u20136.","journal-title":"Nature."},{"key":"4401_CR26","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1128\/MCB.23.15.5113-5121.2003","volume":"23","author":"Y Pan","year":"2003","unstructured":"Pan Y, Chen J. MDM2 promotes ubiquitination and degradation of MDMX. Mol Cell Biol. 2003;23:5113\u201321.","journal-title":"Mol Cell Biol"},{"key":"4401_CR27","first-page":"5968","volume":"18","author":"J Peng","year":"2019","unstructured":"Peng J, Chen XL, Cheng HZ, Xu ZY, Wang H, Shi ZZ, et al. Silencing of KCNK15-AS1 inhibits lung cancer cell proliferation via upregulation of miR-202 and miR-370. Oncol Lett. 2019;18:5968\u201376.","journal-title":"Oncol Lett"},{"key":"4401_CR28","doi-asserted-by":"publisher","first-page":"108613","DOI":"10.1016\/j.biopha.2019.108613","volume":"112","author":"T Sun","year":"2019","unstructured":"Sun T, Wu R, Ming L. The role of m6A RNA methylation in cancer. Biomed Pharmacother. 2019;112:108613.","journal-title":"Biomed Pharmacother"},{"key":"4401_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","volume":"31","author":"S Zhang","year":"2017","unstructured":"Zhang S, Zhao BS, Zhou A, Lin K, Zheng S, Lu Z, et al. m(6)A Demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program. Cancer Cell. 2017;31:591\u2013606.e6.","journal-title":"Cancer Cell"},{"key":"4401_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s13105-019-00690-8","volume":"75","author":"J Zhang","year":"2019","unstructured":"Zhang J, Guo S, Piao HY, Wang Y, Wu Y, Meng XY, et al. ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1. J Physiol Biochem. 2019;75:379\u201389.","journal-title":"J Physiol Biochem"},{"key":"4401_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-1105-6","volume":"20","author":"S Chen","year":"2020","unstructured":"Chen S, Zhou L, Wang Y. ALKBH5-mediated m(6)A demethylation of lncRNA PVT1 plays an oncogenic role in osteosarcoma. Cancer Cell Int. 2020;20:34.","journal-title":"Cancer Cell Int"},{"key":"4401_CR32","doi-asserted-by":"publisher","first-page":"8169","DOI":"10.18632\/aging.102311","volume":"11","author":"WC Li","year":"2019","unstructured":"Li WC, Xiong ZY, Huang PZ, Liao YJ, Li QX, Yao ZC, et al. KCNK levels are prognostic and diagnostic markers for hepatocellular carcinoma. Aging. 2019;11:8169\u201382.","journal-title":"Aging."},{"key":"4401_CR33","first-page":"4059","volume":"20","author":"S Liu","year":"2019","unstructured":"Liu S, Jia J, Zhou H, Zhang C, Liu L, Liu J, et al. PTEN modulates neurites outgrowth and neuron apoptosis involving the PI3K\/Akt\/mTOR signaling pathway. Mol Med Rep. 2019;20:4059\u201366.","journal-title":"Mol Med Rep"},{"key":"4401_CR34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrm3330","volume":"13","author":"MS Song","year":"2012","unstructured":"Song MS, Salmena L, Pandolfi PP. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol. 2012;13:283\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4401_CR35","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10637-019-00791-7","volume":"38","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Li X, Li Y, Chen S, Shen X, Dong X, et al. Expression of the PTEN\/FOXO3a\/PLZF signalling pathway in pancreatic cancer and its significance in tumourigenesis and progression. Investig N Drugs. 2020;38:321\u20138.","journal-title":"Investig N Drugs"},{"key":"4401_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.conb.2017.12.008","volume":"48","author":"JY Hwang","year":"2018","unstructured":"Hwang JY, Zukin RS. REST, a master transcriptional regulator in neurodegenerative disease. Curr Opin Neurobiol. 2018;48:193\u2013200.","journal-title":"Curr Opin Neurobiol"},{"key":"4401_CR37","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3389\/fonc.2019.00291","volume":"9","author":"H Jin","year":"2019","unstructured":"Jin H, Liu P, Kong L, Fei X, Gao Y, Wu T, et al. Identification of RE1-silencing transcription factor as a promoter of metastasis in pancreatic cancer. Front Oncol. 2019;9:291.","journal-title":"Front Oncol"},{"key":"4401_CR38","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/cdd.2012.153","volume":"20","author":"S Singh","year":"2013","unstructured":"Singh S, Ramamoorthy M, Vaughan C, Yeudall WA, Deb S, Palit Deb S. Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells. Cell Death Differ. 2013;20:558\u201366.","journal-title":"Cell Death Differ"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04401-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04401-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04401-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T08:14:38Z","timestamp":1699863278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04401-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["4401"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-04401-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]},"assertion":[{"value":"25 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study had been approved by the Ethics Committee of Huai\u2019an Hospital Affiliated to Xuzhou Medical University (Second People\u2019s Hospital of Huai\u2019an City).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"1121"}}